Regional Health Properties (RHEP) CEO Brent Morrison adds 5,403 shares

Rhea-AI Filing Summary

Regional Health Properties, Inc. insider Brent Morrison, who serves as CEO, President, and Director, reported an open‑market purchase of company stock. On 12/04/2025, he bought 5,403 shares of common stock at a price of $1.41 per share. After this transaction, he beneficially owns 203,450 common shares directly and an additional 2,272 shares indirectly through an IRA, increasing his personal stake in the company.

Insider Trade Summary

Net Buyer: 5,403 shares ($7,618)

Net Buy 2 txns

Insider Morrison Brent

Role CEO and President

Bought 5,403 shs ($8K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,403	$1.41	$8K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 203,450 shares (Direct); Common Stock — 2,272 shares (Indirect, By IRA)

Footnotes (1)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/09/2025 - 09:17 AM Learn about SEC filing dates

FAQ

What insider transaction did RHEP report for Brent Morrison?

Brent Morrison, CEO, President, and Director of Regional Health Properties, Inc. (RHEP), reported buying 5,403 shares of common stock in an open‑market transaction.

On what date did the RHEP insider stock purchase occur?

The reported insider purchase of RHEP common stock by Brent Morrison took place on 12/04/2025.

At what price did Brent Morrison buy RHEP shares?

Brent Morrison purchased the 5,403 RHEP common shares at a price of $1.41 per share.

How many RHEP shares does Brent Morrison own after the transaction?

Following the transaction, Brent Morrison beneficially owns 203,450 RHEP common shares directly and 2,272 shares indirectly through an IRA.

What is Brent Morrison’s role at Regional Health Properties, Inc. (RHEP)?

Brent Morrison is a Director of Regional Health Properties, Inc. and also serves as its CEO and President, according to the filing.

Is the Form 4 for RHEP filed by more than one reporting person?

No. The Form 4 for RHEP is indicated as being filed by one reporting person, Brent Morrison.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morrison Brent

(Last) (First) (Middle)

C/O REGIONAL HEALTH PROPERTIES, INC

1050 CROWN POINTE PARKWAY SUITE 720

(Street)

ATLANTA GA 30338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGIONAL HEALTH PROPERTIES, INC [ RHEP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/04/2025		P		5,403	A	$1.41	203,450	D
Common Stock								2,272	I	By IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brent Morrison	12/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.